Found: 10
Select item for more details and to access through your institution.
Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
- Published in:
- Glia, 2016, v. 64, n. 8, p. 1298, doi. 10.1002/glia.23003
- By:
- Publication type:
- Article
Evaluation of In Vitro Metabolism- and Transporter-Based Drug Interactions with Sunscreen Active Ingredients.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 8, p. 1613, doi. 10.1007/s11095-024-03746-7
- By:
- Publication type:
- Article
Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies.
- Published in:
- Biopharmaceutics & Drug Disposition, 2012, v. 33, n. 5, p. 246, doi. 10.1002/bdd.1790
- By:
- Publication type:
- Article
Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Trends in FDA Transporter‐Based Post‐Marketing Requirements and Commitments Over the Last Decade.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 635, doi. 10.1002/cpt.2701
- By:
- Publication type:
- Article
In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Genotype and Haplotype Analysis of ABCB1 at 1236, 2677 and 3435 among Jordanian Population.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2015, v. 14, n. 6, p. 1013, doi. 10.4314/tjpr.v14i6.11
- By:
- Publication type:
- Article
Overview of Clinical Pharmacology Packages of New Drug Applications Approved for the Treatment of Rare Diseases.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, p. S72, doi. 10.1002/jcph.2167
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and tolerability of BMS‐986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 10, p. 1791, doi. 10.1111/cts.13581
- By:
- Publication type:
- Article
Design and conduct considerations for studies in patients with hepatic impairment.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 1, p. 50, doi. 10.1111/cts.13428
- By:
- Publication type:
- Article